Manual Pressure and ShotBlocker to Reduce Needle-Related Pain and Fear
Effects of Applications Manual Pressure and ShotBlocker to Reduce Needle-Related Pain and Fear in Children With Type 1 Diabetes Mellitus
1 other identifier
interventional
90
1 country
1
Brief Summary
This experimental, prospective, and randomized controlled study was designed to determine and compare the effects of applying manual pressure and ShotBlocker methods in reducing pain and fear during the subcutaneous insulin injection for children with Type 1 diabetes mellitus. A parallel trial design was used describing two intervention (manual pressure and ShotBlocker) and a control group (no intervention used) as the third arm. The study population consisted of children aged 6-12 years, diagnosed with Type 1 diabetes mellitus, administered insulin injections, able to cognitively score their pain and fear levels, who wanted to participate in the study, and gave verbal and written consent to participate in the study.The study sample composed of 90 children based on confidence interval of 95% and statistical power of 80%. Each intervention and control group was matched in terms of gender. In the study, the randomization of the sample group was performed by using stratification and block randomization methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Sep 2022
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
March 16, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedMarch 29, 2023
March 1, 2023
5 months
March 16, 2023
March 16, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Pain Severity
Wong-Baker FACES Pain Rating Scale was used to assess the pain levels of children before and after the insulin administration. This scale was administered to the children, their parents, and a researcher (the first author) within 5 minutes before and immediately after the insulin administration. The scale was scored blindly before and after the insulin administration so that they were not affected by each other.
5 Months
Fear Severity
Child Fear Scale was used to assess pain-related fear levels of children before and after the insulin administration. This scale was administered to the children, their parents, and a researcher (the first author) within 5 minutes before and immediately after the insulin administration. The scale was scored blindly before and after the insulin administration so that they were not affected by each other.
5 Months
Study Arms (3)
Manuel pressure group
EXPERIMENTAL10-second manual pressure was applied on the insulin injection area. The injection point was pressed by the diabetes nurse's right thumb over the site until resistance was felt and the pressure was then maintained for 10 seconds before the insulin injection. Then insulin injection was administered.
ShotBlocker group
EXPERIMENTALShotBlocker device was placed in the insulin injection site by contacting the protruding surface with the skin and was kept throughout the injection. The injection was applied through the opening at the middle of the tool.
Control group:
EXPERIMENTALNo intervention was performed to reduce pain and fear.
Interventions
10-second manual pressure was applied on the insulin injection area.
ShotBlocker device was placed in the insulin injection site by contacting the protruding surface with the skin and was kept throughout the injection. The injection was applied through the opening at the middle of the tool.
Eligibility Criteria
You may qualify if:
- administered insulin injection, able to score cognitively pain and fear levels, who want to participate in research children who gave verbal and written consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Çankırı Karatekin Universitylead
- Istanbul Saglik Bilimleri Universitycollaborator
Study Sites (1)
Çankırı Karatekin Univesity
Çankiri, 18200, Turkey (Türkiye)
Related Publications (1)
Girgin BA, Gol I, Gozen D, Carikci F, Kirmizibekmez H. Effects of applications manual pressure and shotblocker to reduce needle-related pain and fear in children with type 1 diabetes mellitus. J Pediatr Nurs. 2023 Nov-Dec;73:84-90. doi: 10.1016/j.pedn.2023.08.024. Epub 2023 Aug 30.
PMID: 37651942DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
March 16, 2023
First Posted
March 29, 2023
Study Start
September 10, 2022
Primary Completion
February 15, 2023
Study Completion
February 15, 2023
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share